BE, I'm sorry but they completely dropped the ball on this one. There is no way they had insufficient supply. It is clear they never want to enter the USA IF market, even if the opportunity was handed to them on a platter. What is their end game in USA, if never IF or toddler formula?
You see a deliberate decision, whereas I see poor planning and inability to seize an opportunity when it comes along. Did you see the response they've been providing to shareholders on this question? It was a cut and paste response that was clearly drafted from before the current shortage. They stated it was an 18-24 month process to gain approval. And yet here it is given to Bubs virtually overnight. Unacceptable if you ask me.
A2M Price at posting:
$4.32 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)